Insomnia Market Set to Witness Significant Growth with a Promising CAGR of 5.30%

New Market Report Reveals Impressive Growth Prospects for the Insomnia Market, with a projected Compound Annual Growth Rate (CAGR) of 5.30%. The market is expected to reach a value of US$ 6.13 billion by 2030.This indicates a promising trajectory for insomnia treatment solutions, as the demand for effective remedies continues to surge.

Advertisements

Insomnia Market, By Therapy Type (Pharmacological Therapy and Non Pharmacological Therapy), By Drug Formulation (Capsules and Tablets), By Type of Diseases (Poor Quality of Sleep and Sleep Maintenance), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2030

Key Highlights:

In 2017, The European Sleep Research Society has laid down guidelines for the diagnosis alongside the treatment of patients suffering from insomnia. The guidelines laid further talk about the use of light therapy and exercise that are seen as potential and useful getaways to treat insomnia. However, the evidence for the same is weak and low as of now.

According to industry analysts, the insomnia market is poised for substantial growth in the coming years. Factors such as the rising prevalence of insomnia disorders, increasing awareness about the importance of sleep health, and advancements in treatment options are expected to drive market expansion. The projected CAGR of 5.30% indicates a lucrative opportunity for companies operating in this sector. Analysts believe that innovative therapies, including cognitive behavioral therapy for insomnia (CBT-I) and personalized sleep management solutions, will play a pivotal role in meeting the growing demand for effective insomnia treatments.

Competitive Landscape:

Key players operating in the global insomnia market include Eisai, Co., Pfizer, Inc., Merck & Co Inc., Sanofi SA, Takeda Pharmaceutical Company, Meda Consumer Healthcare Inc., Pernix Therapeutics, Purdue Pharma L.P., Consumer Healthcare Inc., and Dainippon Sumitomo Pharma Ltd.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.